Scholarly papers in 2022
We present an overview of papers published in international medical journals based on the EMPIRE data.
- Májek O, Gregor J, Moğulkoç N, Lewandowska K, Šterclová M, Müller V, et al. Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone. PLoS ONE 2022; 17(9): e0273854.
- Nagy T, Toth NM, Palmer E, Polivka L, Csoma B, Nagy A, Clinical predictors of lung-function decline in systemic-sclerosis-associated interstitial lung disease patients with normal spirometry. Biomedicines 2022; 10(9): 2129.
- Jovanovic DM, Šterclová M, Moğulkoç N, Lewandowska K, Müller V, Hájková M, et al. Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study. Respiratory Research 2022; 23(1): 135.
31. 10. 2022
   |
  |